Jay Olson of Oppenheimer, Maintained "Amgen Inc." (AMGN) at Buy with Increased Target from $285 to $290 on, Jun 1st, 2022.
Jay has made no other calls on AMGN in the last 4 months.
There are 8 other peers that have a rating on AMGN. Out of the 8 peers that are also analyzing AMGN, 7 agree with Jay's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- David Risinger of "SVB Leerink" Initiated at Hold and Held Target at $256 on, Monday, May 23rd, 2022
- Salim Syed of "Mizuho" Maintained at Hold with Increased Target to $208 on, Tuesday, May 10th, 2022
- Evan Seigerman of "BMO Capital" Maintained at Hold with Decreased Target to $243 on, Thursday, April 28th, 2022
- Gregory Renza of "RBC Capital" Maintained at Hold with Increased Target to $223 on, Thursday, April 28th, 2022
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $237 on, Tuesday, April 12th, 2022
- Carter Gould of "Barclays" Maintained at Hold with Increased Target to $236 on, Tuesday, April 12th, 2022
- Mohit Bansal of "Wells Fargo" Maintained at Hold with Increased Target to $250 on, Wednesday, February 9th, 2022
This is the rating of the analyst that currently disagrees with Jay
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $260 on, Thursday, April 28th, 2022
